Update on Bio-identical Hormones

[Guest guest]

Subject: Fw: Update: Congress Hears from Thousands of BHRT PatientsDate: Fri, 15 Feb 2008 16:36:36 -0600 Update: Congress

Hears from Thousands of BHRT Patients February 14, 2008 Edition 12 What is P2C2? Why am I receiving this newsletter? Your access to customized, compounded medicines is at risk. Pharmaceutical

manufacturers and the FDA are pushing policies that would make it harder for professionals to prescribe, pharmacists to prepare and patients to take compounded medicines. That's why Patients and Professionals for Customized Care, also known as P2C2, is bringing together people who rely on customized, compounded medicines for better health. Whether you are a patient or a physician, a pet owner or a veterinarian, P2C2 will give you the tools you need to keep pharmaceutical manufacturers and the FDA from restricting your access to compounded medicines. With your free membership to P2C2, you'll be receiving Custom Care

Times, an electronic newsletter that will keep you up-to-date on the latest news and information that affects your ability to take or prescribe compounded medications. Custom Care Times will let you know when your action is needed, and P2C2 will give you the online tools to let your representative in Congress, officials at the FDA or even relevant members of the media know that you or your patients rely on compounded medicines and that you are committed to making sure they remain available. Our strength is in our numbers. The more patients, physicians, pet owners or veterinarians we have fighting for compounded medicines, the more

successful we'll be. Forward this newsletter to your friends. Tell them to join the fight. If you received this newsletter from P2C2 directly, you are already a member. If a friend forwarded this newsletter to you, join P2C2 for free by clicking here. Contact Us info@... Update: Congress Hears from Thousands of Bioidentical Hormone Patients! And the Fight Continues! Dear jan: Last month, the FDA and Wyeth took a major step to restrict women’s access to

bioidentical hormones. In response, P2C2 launched an effort to help women ask their members of Congress to save their access to compounded bioidentical hormones. In just the first 24 hours, more than 2,000 people took action. To date, more than 8,100 people have written letters. This is a strong start, and OUR MESSAGE IS GETTING THROUGH! If you wrote a letter, you may have received a response from FDA. If so, click here to read why what the FDA is saying in those letters is

misleading. We are moving into the second phase of our campaign to save your access to bioidentical hormones. As part of this, we are working with our allies on Capitol Hill to make a strong statement in support of bioidentical hormones. We will need your help, so look for an update from P2C2 in the coming weeks with information on how you can stay involved! When Wyeth asked FDA to take this action two years ago, 70,000 people wrote to the FDA and asked them to reject this policy. That was a tremendous record-breaking response, but FDA ignored women and listened to

Wyeth! That’s why we’re taking our message to Congress this time... and WE NEED YOUR HELP! Stay tuned to http://www.savemymedicine.org/ to ensure you’re up to date on the latest BHRT news! (To learn more about how your access to bioidentical hormones may be at risk, click here.)More to come

soon... What is SaveMyMedicine.org? SaveMyMedicine.org is the online home of Patients and Professionals for Customized Care. Here, you'll be able to find the latest news, issue alerts and information on pharmacy compounding and related issues.

Compounding in the News Check here often to read the latest news stories on compounding, Wyeth, and other issues. Action Alerts Write a letter to your members of Congress

to inform them how compounding affects you and how important it is that your access to compounded medicines is protected. Tell Us Your Story Submit a testimonial that illustrates how pharmacy compounding has made a difference in your life. Your stories will help thousands learn more about the importance of customized care and the impact it has on its patients. P2C2 is an affiliate of the International Academy of Compounding Pharmacists. You are receiving this newsletter because you either (1) signed up for P2C2, (2) used IACP's pharmacy referral service, or (3) used P2C2's website to send a letter to your member of Congress or submit a testimonial. If you have received this email in error or if you would like to opt-out of all future correspondences, please click here.

Never miss a thing. Make Yahoo your homepage.